¸ð½Ã´Â±Û ÇÁ·Î±×·¥ ÃÊ·ÏÁ¢¼ö »çÀüµî·Ï ¹ßÇ¥ÀÚ ¾È³» ¼ö»óÀÚ ¾È³» Çà»çÀå¾È³» ¼÷¹Ú¾È³» Ȩ

Æ÷½ºÅÍ À¯ÀÇ»çÇ×

9¿ù 30ÀÏ(¸ñ) ¿ÀÀü 9½Ã ÀÌÀü±îÁö Æ÷½ºÅ͸¦ ºÎÂøÇÏ¿© Áֽñ⠹ٶø´Ï´Ù.
¿ÀÀü 9½ÃºÎÅÍ "ÃÖ¿ì¼ö Æ÷½ºÅÍ»ó" ½É»ç°¡ ½ÃÀ۵˴ϴÙ.

1. Å© ±â : 63.6cm(°¡·Î) X 93.6cm(¼¼·Î)
2. ¼³Ä¡¹æ¹ý : Final ÇÁ·Î±×·¥Áö¿¡ °ÔÀçµÈ ÃÖÁ¾ Æ÷½ºÅÍ ¹øÈ£¸¦ ¹Ýµå½Ã È®ÀÎÇÑ ÈÄ,
        ÇØ´ç Æ÷½ºÅÍ ÆdzÚÀÇ ÇÏ´Ü°ú »ó´ÜÀ» ¸ÂÃß¾î ºÎÂø ºÎÂøÀç·á´Â °³º°Áغñ
3. Àü½Ã±â°£ : 2010³â 9¿ù 30ÀÏ(¸ñ) ¿ÀÀü 9½Ã ~ 10¿ù 1ÀÏ(Åä) ¿ÀÀü 11½Ã

10¿ù 1ÀÏ(Åä) ¿ÀÀü 11½ÃºÎÅÍ Æ÷½ºÅÍ ÆdzÚÀÌ Ã¶¼öµÇ¿À´Ï ¿ÀÀü 10½Ã~11½Ã »çÀÌ¿¡ Æ÷½ºÅ͸¦ Å»ÂøÇϽñ⠹ٶø´Ï´Ù.

Æ÷½ºÅÍ - Àüü   /    ¸ðüžÆÀÇÇР  /    »ý½Ä³»ºÐºñÇР  /    ºÎÀÎÁ¾¾çÇР  /    ÀϹݺÎÀΰúÇÐ

[ Æ÷½ºÅÍ - ºÎÀÎÁ¾¾çÇÐ ]

Exhibition Hall B
¹øÈ£ ¼º¸í ¼Ò¼Ó Á¦¸ñ
GO1 ¼­µ¿ÈÆ ¼­¿ïÀÇ´ë Prognostic scoring system for optimal management in early invasive cervical cancer found after inadvertent simple hysterectomy
GO2 ±èº¸¿í ¿¬¼¼ÀÇ´ë The prognosis of high risk partial mole : a retrospective review of 15 years
GO3 ¹ÚÇöÁ¾ ¿¬¼¼ÀÇ´ë °ñ¹Ý ³» °¨¿°¼º Áúȯ°ú ÁøÇàµÈ »óÇǼº ³­¼Ò¾ÏÀÇ ¼ö¼ú Àü °¨º°¿¡ ÀÖ¾î ¿µ»ó°Ë»ç, CA125, ±×¸®°í Á¾¾ç ºÎÇÇÀÇ ÀÇÀÇ
GO4 ÇãÁö¼ö ¿¬¼¼ÀÇ´ë Increased neuroepithelial cell transforming 1(NET 1) protein expression in ovarian cancer
GO5 ¹éÁöÈì ¿¬¼¼ÀÇ´ë Clinical impact of high mobility group box 1 protein in epithelial ovarian cancer
GO6 ±èÁøÈÖ °¡Å縯ÀÇ´ë The prognostic impact of anemia in advanced epithelial ovarian cancer
GO7 Á¤±Ù¿À °æºÏÀÇ´ë Initial surgical outcomes of robotic radical hysterectomy compared with laparoscopic-assisted radical vaginal hysterectomy and total laparoscopic radical hysterectomy
GO8 È«´ë±â °æºÏÀÇ´ë The factors affecting surgical margin positive after loop electroexicional procedure on cerical lesion from mild dysplasia to microinvasive cervical carcinoma
GO9 ¹Ú³»À± °æºÏÀÇ´ë Oncologic results and surgical morbidity of laparoscopic staging operation in endometrial cancer
GO10 Àå¹Î¿µ ¿¬¼¼ÀÇ´ë A randomized phase II trial to evaluate the effects of red ginseng on the quality of life in gynecologic cancer patients
GO11 ¹èÁ¾¿î ¼º±Õ°üÀÇ´ë Laparoscopic lymphadenectomy for gynecologic malignancies: Our surgical approach and outcomes, A 7-year experience in a single hospital
GO12 ±è±âµ¿ ¿øÀڷº´¿ø Guideline Adherence to Chemotherapy Administration Safety Standards: A Survey on Nurses in Single Institute
GO13 ÀåÇÏ±Õ °¡Å縯ÀÇ´ë Surgical patterns in management of uterine sarcoma; CMC experiences
GO14 ¹èÁ¾¿î ¼º±Õ°üÀÇ´ë Pitfalls to avoid while you are working at the paraaortic region: Vascular anomalies or variants
GO15 ¼­µ¿¼ö ºÎ»êÀÇ´ë Significance of periostin expression in epithelial ovarian cancer
GO16 È«´ë±â °æºÏÀÇ´ë Laparoscopic tansperitoneal paraaortic lymphadenectomy with or without infrarenal lymphadenectomy in cervical carcinoma.
GO17 °­¿ì´ë Àü³²ÀÇ´ë Significance of human papillomavirus genotyping in prognosis of stage IB-IIA cervical carcinoma undergoing radical hysterectomy
GO18 °ûÇö¼º °¡Å縯ÀÇ´ë Statistical analysis of prognostic factors on survival outcome of patients with early stage endometrial carcinoma
GO19 ±è¹Î±Ô ¼º±Õ°üÀÇ´ë Characterization of synchronous gynecologic cancers: a single institution review of 44 cases
GO20 ±è¹Î±Ô ¼º±Õ°üÀÇ´ë Clinical significance of HIF-2¥á immunostaining area in radioresistant cervical cancer
GO21 ±è¹Î±Ô ¼º±Õ°üÀÇ´ë Clinical Significances of Galectin-3 Expression in Ovarian Carcinomas
GO22 ±è¹Î±Ô ¼º±Õ°üÀÇ´ë Phase II study of Ifosfamide and cisplatin in recurrent ovary cancer
GO23 ±è¹Î±Ô ¼º±Õ°üÀÇ´ë High expression of mTOR is associated with radiation resistance in cervical cancer
GO24 ±è¼ö³ç °Ç±¹ÀÇ´ë TELECERVICOGRAPHY FOR CERVICAL CANCER SCREENING
GO25 ±è¿µÀç ÇѾçÀÇ´ë Development of New Risk of Malignancy Indices for Detecting Malignant Adnexal Masses
GO26 ±è¿ì¿µ ¾ÆÁÖÀÇ´ë Role of MRI as an exclusion criteria for bladder or rectum invasion in cervix cancer
GO27 ±èÀ±È¯ ¼­¿ïÀÇ´ë Learning curve for single-port-access laparoscopic surgery in benign adnexal mass.
GO28 ±èÇÏÁ¤ ¼º±Õ°üÀÇ´ë Relative influences of specific anatomic tumor regions before primary cytoreduction on survival for patients with advanced ovarian cancer
GO29 ±èÇÏÁ¤ ¼º±Õ°üÀÇ´ë Prediction of surgical outcome in patients with advanced ovarian cancer using computed tomography and operative findings
GO30 ³ë¿µÈ£ ¿¬¼¼ÀÇ´ë Clinical impact of aggressive treatment in patients with brain metastases from epithelial ovarian cancer
GO31 ¹®ÈñÇö Àü³²ÀÇ´ë DISTRIBUTION OF HIGH-RISK HUMAN PAPILLOMAVIRUS GENOTYPES AMONG OLDER WOMEN
GO32 ¹Ú¼±°æ ¿ï»êÀÇ´ë The Impact of Tumor Morcellation during Surgery on the Prognosis of Patients with Apparently Early Uterine Leiomyosarcoma(LMS)
GO33 ¹ÚÁ¤¿­ ¿ï»êÀÇ´ë ki-67 as a strong prognostic indicator in endometrial stromal sarcoma
GO34 ¹ÚÁ¤¿­ ¿ï»êÀÇ´ë Oncologic and reproductive outcomes of patients with ovarian yolk sac tumor after bleomycin, etoposide, cisplatin (BEP) chemotherapy following surgery
GO35 ¹ÚȲ½Å ¼º±Õ°üÀÇ´ë Small cell neuroendocrine carcinoma of the cervix: a clinical study of 16 patients in single institute
GO36 ¹è¼ºÁØ ¼­¿ïÀÇ´ë Prognosis prediction with basal eosinophil count in the patients with epithelial ovarian cancer
GO37 º¯Á¤¹Ì ÀÎÁ¦ÀÇ´ë Àç¹ß¼º ÀڱðæºÎ¾ÏÀÇ ¼¼Æ÷ ÇüÅ¿¡ µû¸¥ ÀüÀÌ ÇüÅ ºÐ¼®
GO38 ¼­µ¿ÈÆ ¼­¿ïÀÇ´ë The old age itself is not an independent poor prognostic factor in epithelial ovarian cancer (EOC).
GO39 ¼Û¹ÎÁ¾ °¡Å縯ÀÇ´ë Comparison of PNA based array with DNA-based array for detecting and genotyping Human Papillomavirus
GO40 ¼Û¿ëÁß ºÎ»êÀÇ´ë Persistent human papillomavirus DNA is associated with local recurrence after radiotherapy of uterine cervical cancer
GO41 ¼ÛÅÂÁ¾ ¼º±Õ°üÀÇ´ë Pediatric Borderline Ovarian Tumors: A Retrospective Analysis
GO42 ÀÌ°æ¹Ì ¾ÆÁÖÀÇ´ë ¿ø¹ß¼º ³­°ü¾Ï°ú ³­¼Ò¾Ï ȯÀÚÀÇ Áõ·Ê ¦Áþ±â¸¦ ÅëÇÑ ¿¹ÈÄ ºñ±³ ¿¬±¸
GO43 ÀÌ»óÈÆ ¿ï»êÀÇ´ë Accuracy of intraoperative frozen section for mucinous ovarian tumors
GO44 À̼ºÁ¾ °¡Å縯ÀÇ´ë Correlation between cervicography impression and cervical histology in private clinics in Korea
GO45 ÀÌ¿ì¼® ¼º±Õ°üÀÇ´ë Clinical Outcome of Lymphoepithelioma-like Carcinoma of the Uterine Cervix
GO46 ÀÌÀ¯¿µ ¼º±Õ°üÀÇ´ë A comparison of pure adenocarcinoma and squamous cell carcinoma of the cervix after radical hysterectomy in stage IB-IIA
GO47 ÀÌÀ¯¿µ ¼º±Õ°üÀÇ´ë Preoperative neutrophil-lymphocyte ratio as a prognostic factor in early cervical cancer patients treated with radical hysterectomy
GO48 ÀÌÀº½Ç °¡Å縯ÀÇ´ë Single-port laparoscopic cystectomy for benign adnexal cyst using conventional rigid straight instruments
GO49 ÀÌÁ¤¿ø °¡Å縯ÀÇ´ë ½ÅÀå À̽ÄÀ» ¹ÞÀº ȯÀÚ¿¡¼­ ¹ß»ýÇÑ ÀڱðæºÎ¾ÏÀÇ ¹ß»ýÀ²°ú ÀÓ»ó-º´¸®ÇÐÀû Ư¡
GO50 ÀÌÁ¤¿ø °¡Å縯ÀÇ´ë Distribution of Human Papillomavirus Type 16 E6 and E7 Gene Variants in the Progression of Cervical Dysplasia in Korean Women
GO51 ÀÌÁ¤¿ø ¼º±Õ°üÀÇ´ë The Influences of Surgical Stress on Ovarian Carcinoma Growth in an Animal Model: Laparoscopy vs. Laparotomy
GO52 ÀÌÁ¤¿ø ¼º±Õ°üÀÇ´ë Differential expression of MicroRNA and Messenger RNA in Paclitaxel-Resistant Ovarian Cancer Cells
GO53 ÀÓ¸íö ±¹¸³¾Ï¼¾ÅÍ Sexual function at time of diagnosis of pre-invasive disease of cervix or cervical cancer: analysis from prospective database
GO54 ÀÓÇü¼ö ¼­¿ïÀÇ´ë Clinical Analysis of 15 Cases of Low Grade Endometrial Stromal Sarcoma
GO55 Á¤ÀºÁ¤ ÀÎÁ¦ÀÇ´ë ÀÚ±ÃÀ°Á¾ 55·Ê¿¡ ´ëÇÑ ÀÓ»óÀû °íÂû ¹× ¿¹ÈÄ
GO56 Á¶ÁöÇý °æ»óÀÇ´ë Expression of p16, p53 and P-p53 proteins in cervical cancer
GO57 ÇÏÀçÀº °¡Å縯ÀÇ´ë Clinical analysis of borderline ovarian tumors
GO58 ȲÁ¾ÇÏ ±¹¸³¾Ï¼¾ÅÍ A early phase II study of belotecan (CKD 602) as a single agent second line therapy in patients with recurrent or progressive carcinoma of uterine cervix
GO59 °í¾Æ¶ó ÇѸ²ÀÇ´ë Àç¹ß¼º ÀڱøñÆíÆò»óÇdz»¾Ï¿¡ µ¿¹ÝµÈ ÀڱüӸ·ÀÇ ÆíÆò»óÇdz»¾ÏÁ¾
GO60 °ø°Ç¿µ ¿ï»êÀÇ´ë ÀÚ±ÃÀÇ ¾Ç¼º ¹Ä·¯ ¼±À°Á¾(mullerian adenosarcoma): ´ÜÀϱâ°üÀÇ 9¿¹ ÀÓ»óºÐ¼®
GO61 ±è³²ÀÇ ÀüÁÖ¿¹¼öº´¿ø Ãæ¼öµ¹±â¿°¿¡ µ¿¹ÝµÈ ³­¼ÒÀÇ ³¶¼¶À¯¼±Á¾ 1 ¿¹
GO62 ±è¾Æ¶ó ÇѸ²ÀÇ´ë Ovarian metastasis after the surgery and schedule chemotherapy of the Gallbladder
GO63 ±è¿ë¿í °¡Å縯ÀÇ´ë Single-Port Laparoscopic Pelvic Lymph Node Dissection with Radical Vaginal Hysterectomy in Cervical Cancer
GO64 ±èÁöÇö ÇѸ²ÀÇ´ë ÀڱðæºÎÀÇ ½Å°æ³»ºÐºñ¾ÏÁ¾ 1¿¹
GO65 ±èÁøÈÖ °¡Å縯ÀÇ´ë Leiomyosarcoma arising in a patient with prior mitotically active leiomyoma
GO66 ¹Ú¼ºÅà °¡Å縯ÀÇ´ë Synchronous occurrence of primary neoplasms in the uterus with clear cell carcinoma of the cervix and adenocarcinoma of the endometrium
GO67 ¹èÁ¦ÁØ ¿µ³²ÀÇ´ë Surgical Management of Huge Uterine myoma: Two or three -incision laparoendoscopic single-site surgery (LESS) using conventional trocar
GO68 ¹èÁ¦ÁØ ¿µ³²ÀÇ´ë Surgical Management of Large Cystic Ovarian Tumor: Two-incision Laparoscopic-Assisted Transumbilical Extracorporeal Ovarian Cystectomy (LATEC)
GO69 ¹èÁ¦ÁØ ¿µ³²ÀÇ´ë Primary malignant melanoma of the vagina following breast cancer: a case report.
GO70 º¯Àçõ µ¿¾ÆÀÇ´ë Soft tissue metastasis of immature teratoma of the ovary: a case report
GO71 ¼Û¹ÎÁ¾ °¡Å縯ÀÇ´ë Parovarian Tumors of Borderline Malignancy
GO72 ¼Û¿ëÁß ºÎ»êÀÇ´ë A case of collision tumor of ovary associated with mature teratoma
GO73 ½ÅÁ¤±Ô °æ»óÀÇ´ë Cyclooxygenase-2 over-expression correlates with HIF-1¥á & BCL-2 in Cervical Cancer Tissue
GO74 À¯¹ÎÁö °í·ÁÀÇ´ë PRIMARY SEROUS PAPILLARY PERITONEAL CARCINOMA ARISING FROM SUPERNUMERARY OVARY IN MAYER-ROKITANSKY-KUSTER-HAUSER SYNDROME (MRKH)
GO75 À¯ÇåÁ¾ Ãæ³²ÀÇ´ë Leiomyoma mimicking ovarian cancer after total abdominal hysterectomy
GO76 À±º¸Çö ¿¬¼¼ÀÇ´ë A case of isolated peritoneal metastasis in clinical early stage squamous cell carcinoma of cervix
GO77 ÀÌ´ë¿ì °¡Å縯ÀÇ´ë A case of extensive vulvar intraepithelial neoplasia with concomitant anal intraepithelial neoplasia in a young woman
GO78 ÀÌ¹é ¿¬¼¼ÀÇ´ë A case of stomach cancer metastatic to the uterine cervical cancer
GO79 ÀÌ¿ø¹« ¿øÀڷº´¿ø Laparoscopic treatment of pararenal unicentric hyaline vascular type of Castleman¡¯s disease coexisted with malignant Brenner tumor
GO80 ÀÌÁ¾½É ¿ï»êÀÇ´ë Mature Cystic Teratomas in Ovary and Immature Teratoma in Mediastinum
GO81 Á¤¼±¿í °è¸íÀÇ´ë Peritoneal metastasis in primary cervical cancer
GO82 Á¤ÇöÀç ÀÎÇÏÀÇ´ë A patint with endometrial cancer with SMA thrombosis after adjuvant CCRT
GO83 ÃÖÀÏÁ¤ µ¿¾ÆÀÇ´ë Invasive carcinoma of cervix in a patient with double cervices ; a case report
GO84 Çϸ¸Åà °æ»óÀÇ´ë Hypoxia reduces expression of transforming growth factor, beta 1 in the human choriocarcinoma cell line JEG-3
GO85 Çã¼ö¿µ °¡Å縯ÀÇ´ë Cervical adenoid basal carcinoma associated with invasive squamous cell carcinoma: A report of rare co-existence and review of literature.
GO86 ¿ÀÁö¿µ °í½ÅÀÇ´ë The relationship between endometrial cancer and bone density